Irving Magee Investment Management’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-77,676
Closed -$2.69M 18
2017
Q1
$2.69M Hold
77,676
1.03% 48
2016
Q4
$2.74M Hold
77,676
1.06% 47
2016
Q3
$2.7M Buy
77,676
+1
+0% +$35 1.22% 42
2016
Q2
$2.9M Hold
77,675
1.42% 36
2016
Q1
$3.14M Hold
77,675
1.59% 32
2015
Q4
$2.79M Hold
77,675
1.43% 35
2015
Q3
$2.48M Buy
77,675
+1
+0% +$34 1.29% 41
2015
Q2
$2.64M Hold
77,674
1.15% 46
2015
Q1
$2.63M Hold
77,674
1.14% 43
2014
Q4
$2.73M Buy
77,674
+33
+0% +$1.11K 1.21% 40
2014
Q3
$2.54M Hold
77,641
1.17% 43
2014
Q2
$2.64M Hold
77,641
1.19% 38
2014
Q1
$2.72M Hold
77,641
1.24% 39
2013
Q4
$2.84M Hold
77,641
1.3% 36
2013
Q3
$2.69M Hold
77,641
1.36% 35
2013
Q2
$2.63M Buy
+77,641
New +$2.58M 1.45% 28

Other funds holding ACH

Irving Magee Investment Management's ACH Position: Q2 2017 in Review

Irving Magee Investment Management sold out of Accendra Health (ACH) in Q2 2017, closing a stake of 77,676 shares — an estimated $2.69M sold.

Irving Magee Investment Management first reported a position in ACH in Q2 2013 and held it in 16 quarters. The position peaked at $3.14M in Q1 2016. 273 funds tracked by Wall St. Rank hold ACH as of Q2 2017.

  • Irving Magee Investment Management reported no remaining Accendra Health position as of Q2 2017 after selling out during the quarter.
  • Irving Magee Investment Management sold 77,676 Accendra Health shares in Q2 2017, an estimated $2.69M.
  • Irving Magee Investment Management first reported a position in Accendra Health in Q2 2013 and held it in 16 quarters.
  • Irving Magee Investment Management's Accendra Health position peaked at $3.14M in Q1 2016.
  • 273 funds tracked by Wall St. Rank held Accendra Health as of Q2 2017.

Based on Irving Magee Investment Management's 13F filing for Q2 2017.